IT heavyweight TCS December quarterly results has come. in the fiscal year 2017 third quarter, the profit of company increased 2.9% to Rs 6778 crore, in the second quarter the profit was Rs 6586 crore. In the third quarter, the income of the company is increased 1.5% to Rs 2975 crore, and dollar income increased… Read More

The effect of financing problem in the US has had on complete Pharma sector, but Glenmark is focusing on the US despite competition. According to the source, the company has focused on Cancer, Breathing, and Skin related medicines. The company has decided to spend 11% of their sales on R&D. In India the company position… Read More